Journal
PEERJ
Volume 4, Issue -, Pages -Publisher
PEERJ INC
DOI: 10.7717/peerj.2300
Keywords
Cell therapy; Minimum information model; Antigen-presenting cells; Autoimmune disease; Transplantation; Tolerogenic dendritic cells; Regulatory macrophages; Reporting guidelines
Categories
Funding
- European Cooperation in Science and Technology (COST) [BM1305]
- Medical Research Council [G1001518] Funding Source: researchfish
- ReumaFonds [14-3-301] Funding Source: researchfish
- Versus Arthritis [18155] Funding Source: researchfish
Ask authors/readers for more resources
Cellular therapies, with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation The methodologies for generating tolAPC vary greatly between different laboratories, making it difficult to compare data from different studies; thus constituting a major hurdle for the development of standardised tolAPC therapeutic products. Here we describe an initiative by members of the tolAPC field to generate a minimum information model for tolAPC (MITAP), providing a reporting framework that will make differences and similarities between tolAPC products transparent. In this way, MITAP constitutes a first but important step towards the production of standardised and reproducible tolAPC for clinical application.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available